GO:0060080 inhibitory postsynaptic potential: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060080 inhibitory postsynaptic potential (IPSP) is a biological process that causes a temporary decrease in postsynaptic membrane potential due to the flow of negatively charged ions into the postsynaptic cell.
• IPSPs are mediated by inhibitory neurotransmitter receptors such as GABA-A and glycine receptors, which open chloride channels, and by glutamate-gated chloride channels in invertebrates [1, 2].
• The resulting inhibitory postsynaptic current (IPSC) makes it more difficult for the neuron to fire an action potential, thereby shaping neural circuit excitability [1, 4].
• IPSPs participate in network oscillations, including hippocampal theta rhythms, and are critical for synchronizing neuronal activity [4, 7].
• Dysregulation of IPSPs is implicated in neurological and psychiatric disorders such as autism spectrum disorder and epilepsy.
• CRISPR-based gene editing enables precise dissection of IPSP-related genes through knockout, point mutation, knock-in, and overexpression models.
Description
Inhibitory postsynaptic potentials (IPSPs) are fundamental electrical signals that transiently hyperpolarize or stabilize the postsynaptic membrane, reducing the probability of action potential firing [1, 3]. This process, annotated as GO:0060080, is essential for maintaining the balance between excitation and inhibition in the nervous system. IPSPs are generated when inhibitory neurotransmitters such as GABA or glycine bind to their receptors, opening ion channels that allow negatively charged ions, primarily chloride, to flow into the postsynaptic cell [1, 2]. The resulting inhibitory postsynaptic current (IPSC) opposes excitatory inputs and shapes the timing and pattern of neuronal output. Researchers study IPSPs to understand how neural circuits process information, how network oscillations emerge, and how disruptions in inhibition contribute to disease [4, 5]. For example, hippocampal theta rhythms depend on precisely timed IPSPs, and alterations in inhibitory synaptic transmission are linked to autism spectrum disorder and epilepsy [4, 5]. The molecular players include GABA-A receptor subunits, glycine receptors, and modulatory proteins such as HCN1 channels that influence GABA release. Advances in CRISPR gene editing now allow targeted manipulation of genes encoding these components, enabling causal tests of their roles in IPSP generation and regulation. This article provides a comprehensive overview of GO:0060080, covering its definition, mechanisms, key genes, disease relevance, and state-of-the-art research methods.
inhibitory postsynaptic potential At A Glance
| GO ID | GO:0060080 |
|---|---|
| GO term | inhibitory postsynaptic potential |
| Ontology | biological_process |
| Synonym | IPSP, regulation of inhibitory post-synaptic membrane potential |
| Major function | Temporary decrease in postsynaptic membrane potential via influx of negatively charged ions, reducing action potential firing |
| Related cellular component | Inhibitory synapse, postsynaptic membrane |
| Related molecular function | Inhibitory neurotransmitter receptor activity (e.g., GABA-A, glycine receptor, GluCl) [1, 2] |
| Key ions | Chloride (Cl-) primarily; sometimes other anions |
| Associated currents | Inhibitory postsynaptic current (IPSC) [1, 7] |
What Is GO:0060080?
GO:0060080 inhibitory postsynaptic potential is defined as a process that causes a temporary decrease in postsynaptic membrane potential due to the flow of negatively charged ions into the postsynaptic cell. The flow of ions that causes an IPSP is an inhibitory postsynaptic current (IPSC) and makes it more difficult for the neuron to fire an action potential. In simpler terms, an IPSP is a brief electrical brake that reduces a neuron's readiness to send signals.
Why Is inhibitory postsynaptic potential Important in Cell Biology?
IPSPs are essential for information processing in the brain, as they control spike timing, prevent runaway excitation, and contribute to network oscillations such as theta rhythms [4, 7]. Disruptions in inhibitory synaptic transmission underlie numerous neurological and psychiatric conditions, including autism spectrum disorder, epilepsy, and anxiety disorders. Understanding the mechanisms of IPSPs is therefore critical for developing targeted therapies and for interpreting how gene mutations alter circuit function.
• IPSPs maintain the excitation-inhibition balance required for stable neural circuit function.
• They shape the timing of action potentials and contribute to coincidence detection.
• IPSPs are involved in hippocampal theta rhythms, which are important for memory and navigation.
• Dysfunctional IPSPs are associated with autism spectrum disorder, as shown in Adnp-mutant mice.
• Inhibitory postsynaptic currents are targets for drugs such as ivermectin, used to treat parasitic infections.
• Zinc modulates inhibitory neurotransmission, highlighting metal ion regulation of IPSPs.
• Miniature IPSCs (mIPSCs) provide a readout of quantal inhibitory release.
• Subcellular imbalances in synaptic activity can affect IPSP generation.
• CRISPR screening can identify genes that regulate IPSP properties.
• IPSPs are conserved across species, from Aplysia to mammals, enabling comparative studies.
What Happens During inhibitory postsynaptic potential?
Neurotransmitter Release and Receptor Activation
In simple terms: The presynaptic neuron releases an inhibitory chemical that binds to receptors on the next neuron.
IPSPs begin when an inhibitory neurotransmitter, such as GABA or glycine, is released from presynaptic terminals and binds to postsynaptic receptors. In invertebrates, glutamate-gated chloride channels (GluClRs) mediate inhibitory postsynaptic currents. In mammals, GABA-A receptors and glycine receptors are the primary mediators. This binding triggers conformational changes that open ion channels.
Ion Flux and Membrane Hyperpolarization
In simple terms: Negatively charged ions flow into the cell, making the inside more negative.
Activation of inhibitory receptors allows negatively charged ions, primarily chloride, to flow into the postsynaptic cell. This influx generates an inhibitory postsynaptic current (IPSC) that temporarily decreases the membrane potential, moving it away from the threshold for action potential firing [1, 7]. The resulting hyperpolarization or shunting inhibition reduces neuronal excitability.
Integration and Effect on Action Potential Firing
In simple terms: The inhibitory signal makes it harder for the neuron to send its own signal.
The IPSP integrates with excitatory inputs at the soma and dendrites. If the summed depolarization does not reach threshold, no action potential is generated. IPSPs can also shunt excitatory currents, further reducing the probability of firing. This integration is critical for coincidence detection and temporal coding.
Role in Network Oscillations
In simple terms: Inhibitory signals help create rhythmic brain waves.
IPSPs participate in intracellular and extracellular theta rhythms in the hippocampus. Synchronized bursts of miniature IPSCs can influence network activity. These oscillations are important for memory, navigation, and sensory processing.
Modulation by Neuromodulators and Ions
In simple terms: Other chemicals can change how strong the inhibitory signal is.
Zinc modulates inhibitory neurotransmission by affecting GABA-A receptors. HCN1 channels enhance evoked GABA release from parvalbumin-positive interneurons, thereby influencing IPSPs. Subcellular imbalances in synaptic activity can also affect inhibitory signaling.
Key Genes Involved in GO:0060080 inhibitory postsynaptic potential
The following genes and proteins are central to the generation, regulation, and study of inhibitory postsynaptic potentials.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GABRA1 | GABA-A receptor alpha-1 subunit; mediates chloride influx | Target for epilepsy and autism studies |
| GABRB2 | GABA-A receptor beta-2 subunit; receptor assembly | Mutations linked to epilepsy |
| GABRG2 | GABA-A receptor gamma-2 subunit; benzodiazepine binding | Epilepsy and anxiety models |
| GLRA1 | Glycine receptor alpha-1; chloride channel in spinal cord | Hyperekplexia and startle disease |
| GLRB | Glycine receptor beta; receptor clustering | Inhibitory synapse formation |
| GluClR | Glutamate-gated chloride channel in invertebrates | Ivermectin target and resistance studies |
| HCN1 | Hyperpolarization-activated cyclic nucleotide-gated channel | Enhances GABA release from PV interneurons |
| PVALB | Parvalbumin; calcium-binding protein in fast-spiking interneurons | Marker for inhibitory interneurons |
| ADNP | Activity-dependent neuroprotective protein; chromatin regulator | Autism spectrum disorder model |
| KCC2 | Potassium-chloride cotransporter; maintains chloride gradient | Determines IPSP polarity |
| NKCC1 | Sodium-potassium-chloride cotransporter; chloride accumulation | Developmental switch in GABA action |
| GAD1 | Glutamate decarboxylase 1; GABA synthesis | Inhibitory neurotransmitter production |
| GAD2 | Glutamate decarboxylase 2; GABA synthesis | Inhibitory neurotransmitter production |
| SLC6A1 | GABA transporter; regulates extracellular GABA | Epilepsy and autism |
| LSD1 | Histone demethylase; epigenetic regulator | Ameliorates synaptic deficits in Adnp mutants |
| ZIP | Zinc transporter; modulates zinc in synapse | Zinc regulation of IPSPs |
| GPHN | Gephyrin; postsynaptic scaffold at inhibitory synapses | Clustering of GABA-A and glycine receptors |
| NLGN2 | Neuroligin-2; inhibitory synapse adhesion | Inhibitory synapse specification |
How Is inhibitory postsynaptic potential Regulated?
IPSPs are regulated at multiple levels. Presynaptically, the release of inhibitory neurotransmitters is influenced by HCN1 channels on parvalbumin-positive interneurons, which enhance evoked GABA release. Postsynaptically, the chloride gradient maintained by KCC2 and NKCC1 determines the strength and polarity of IPSPs. Neuromodulators such as zinc can directly modulate GABA-A receptor function. Epigenetic regulators like LSD1 can influence the expression of synaptic genes, as shown in Adnp-mutant mice where LSD1 inhibition ameliorates synaptic deficits. Additionally, subcellular imbalances in synaptic activity can alter inhibitory signaling.
inhibitory postsynaptic potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADNP | Autism spectrum disorder | Adnp-mutant mouse; LSD1 inhibitor treatment |
| GABRA1 | Epilepsy | Knock-in mouse with patient mutation |
| GLRA1 | Hyperekplexia | Knockout mouse; glycine receptor function |
| GluClR | Ivermectin resistance in parasites | Invertebrate models; electrophysiology |
| HCN1 | Epilepsy and rhythm disorders | HCN1 knockout mouse; PV interneuron recordings |
Autism Spectrum Disorder
Disruptions in inhibitory synaptic transmission are increasingly recognized in autism spectrum disorder. In Adnp-mutant mice, synaptic deficits including altered inhibitory postsynaptic potentials are observed, and inhibition of the histone demethylase LSD1 ameliorates these deficits. This suggests that epigenetic regulation of IPSP-related genes contributes to autism pathology.
Epilepsy
Epilepsy often arises from an imbalance between excitation and inhibition. Mutations in GABA-A receptor subunits (e.g., GABRA1, GABRB2, GABRG2) and glycine receptors (GLRA1, GLRB) can impair IPSP generation, leading to hyperexcitability and seizures [1, 2]. Understanding how these mutations affect IPSCs is crucial for developing targeted therapies.
Parasitic Infections and Drug Resistance
In invertebrates, glutamate-gated chloride channels (GluClRs) mediate inhibitory postsynaptic currents and are the target of ivermectin, a widely used antiparasitic drug. Mutations in GluClR can confer ivermectin resistance, highlighting the clinical importance of IPSP mechanisms in parasites.
Neurological Disorders and Theta Rhythms
IPSPs participate in hippocampal theta rhythms, which are critical for memory and navigation. Disruption of these rhythms has been linked to cognitive deficits in Alzheimer's disease and schizophrenia. Studying IPSP regulation may provide insights into these conditions.
From inhibitory postsynaptic potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IPSP amplitude? | Knockout mouse or CRISPR KO cell line |
| Does a patient mutation alter IPSC kinetics? | Point mutation knock-in mouse |
| How does a risk variant affect inhibitory synapse formation? | Knock-in of variant in human iPSC-derived neurons |
| Where is the protein localized in inhibitory synapses? | Tagged knock-in with fluorescent protein |
| Does overexpression of gene Y enhance inhibition? | Overexpression via viral vectors or transgenic mice |
| What genes modulate ivermectin sensitivity? | CRISPR library screening in invertebrate cells |
How to Study the inhibitory postsynaptic potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | IPSC amplitude, frequency, kinetics | Direct measurement of IPSPs in neurons [1, 7] |
| Miniature IPSC recording | Quantal release probability | Assessing presynaptic inhibition |
| Calcium imaging | Intracellular calcium changes | Monitoring inhibitory network activity |
| RNA-seq | Gene expression changes | Identifying IPSP-related pathways |
| Proteomics | Protein abundance and modifications | Discovering synaptic proteins |
| CRISPR knockout screening | Gene function in IPSP regulation | High-throughput discovery |
| Immunohistochemistry | Localization of inhibitory synapse proteins | Validating receptor clustering |
| Behavioral assays | Seizure susceptibility, social behavior | Linking IPSPs to disease phenotypes |
Electrophysiology
Patch-clamp recordings are the gold standard for measuring inhibitory postsynaptic potentials and currents. They allow direct quantification of IPSC amplitude, decay kinetics, and reversal potential [1, 7]. Miniature IPSCs (mIPSCs) provide information about quantal release.
Imaging and Optogenetics
Genetically encoded calcium indicators and voltage sensors can monitor inhibitory synaptic activity in vivo. Optogenetic activation of inhibitory interneurons combined with imaging reveals how IPSPs shape network dynamics.
Transcriptomics and Proteomics
RNA-seq and proteomics can identify genes and proteins differentially expressed in models of IPSP dysfunction. For example, transcriptomic analysis of Adnp-mutant mice revealed synaptic deficits ameliorated by LSD1 inhibition.
CRISPR Screening
Pooled CRISPR knockout screens can systematically identify genes that regulate inhibitory synaptic transmission. Such screens have been used to discover modulators of ivermectin sensitivity in parasites and could be adapted to mammalian neurons.
How CRISPR Can Be Used to Study GO:0060080 inhibitory postsynaptic potential
Knockout
CRISPR knockout of genes such as GABRA1, GLRA1, or ADNP can abolish or reduce IPSPs, providing causal evidence for their role. For example, Adnp knockout mice exhibit synaptic deficits that are rescued by LSD1 inhibition. Knockout models are essential for validating gene function in inhibitory transmission.
Point Mutation
Introducing patient-specific point mutations (e.g., in GABRG2 or GLRA1) via CRISPR allows precise modeling of how single amino acid changes alter IPSC properties. Such models can reveal mechanisms of epilepsy or hyperekplexia.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci enables real-time visualization of inhibitory synapse proteins. Knock-in of disease variants into human iPSCs followed by differentiation into neurons provides a platform for drug screening.
Overexpression
CRISPR activation (CRISPRa) or viral overexpression can increase expression of genes like HCN1 or GAD1 to enhance inhibitory transmission. Overexpression models help determine sufficiency of a gene in promoting IPSPs.
How EDITGENE Supports inhibitory postsynaptic potential Research
Researchers studying inhibitory postsynaptic potential-related genes often need to determine whether a candidate gene is causally involved in IPSP generation, modulation, or dysfunction. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process, from gene knockout to precise point mutations and high-throughput screening.
Contact EDITGENE today to design your custom CRISPR model for inhibitory postsynaptic potential research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DRD4 Knockout HEK293 Cell Line | EDJ-KQ2237 | Human | 1815 | Details Get a Quote |
| NLGN3 Knockout HEK293 Cell Line | EDJ-KQ3891 | Human | 54413 | Details Get a Quote |
| GABRB3 Knockout HEK293 Cell Line | EDJ-KQ3911 | Human | 2562 | Details Get a Quote |
| CHRNA4 Knockout HEK293 Cell Line | EDJ-KQ4275 | Human | 1137 | Details Get a Quote |
| GLRA1 Knockout HEK293 Cell Line | EDJ-KQ4720 | Human | 2741 | Details Get a Quote |
| SYT1 Knockout HEK293 Cell Line | EDJ-KQ5135 | Human | 6857 | Details Get a Quote |
| NPAS4 Knockout HEK293 Cell Line | EDJ-KQ11911 | Human | 266743 | Details Get a Quote |
| INSYN1 Knockout HEK293 Cell Line | EDJ-KQ13845 | Human | 388135 | Details Get a Quote |
| INSYN2A Knockout HEK293 Cell Line | EDJ-KQ13846 | Human | 642938 | Details Get a Quote |
| GABRB3 Knockout A-549 Cell Line | EDJ-KQ27373 | Human | 2562 | Details Get a Quote |
| SYT1 Knockout A-549 Cell Line | EDJ-KQ29366 | Human | 6857 | Details Get a Quote |
| SYT1 Knockout HCT 116 Cell Line | EDJ-KQ29367 | Human | 6857 | Details Get a Quote |
| NPAS4 Knockout HeLa Cell Line | EDJ-KQ40388 | Human | 266743 | Details Get a Quote |
| INSYN1 Knockout A-549 Cell Line | EDJ-KQ43685 | Human | 388135 | Details Get a Quote |
| INSYN1 Knockout HCT 116 Cell Line | EDJ-KQ43686 | Human | 388135 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About inhibitory postsynaptic potential
What is an inhibitory postsynaptic potential (IPSP)?
An IPSP is a temporary decrease in postsynaptic membrane potential caused by the flow of negatively charged ions into the neuron, making it harder to fire an action potential.
What is GO:0060080?
GO:0060080 is the Gene Ontology term for inhibitory postsynaptic potential, a biological process.
What genes are involved in inhibitory postsynaptic potentials?
Key genes include GABRA1, GABRB2, GABRG2, GLRA1, GLRB, HCN1, ADNP, KCC2, and NKCC1 [1, 2, 5].
How are IPSPs measured?
IPSPs are typically measured using patch-clamp electrophysiology to record inhibitory postsynaptic currents (IPSCs) [1, 7].
What is the difference between IPSP and IPSC?
IPSP is the change in membrane potential, while IPSC is the underlying ion current that causes it.
Which neurotransmitters mediate IPSPs?
GABA and glycine are the primary inhibitory neurotransmitters in mammals; glutamate-gated chloride channels mediate IPSPs in invertebrates [1, 2].
What diseases are associated with abnormal IPSPs?
Abnormal IPSPs are linked to autism spectrum disorder, epilepsy, and hyperekplexia [1, 5].
How does zinc affect IPSPs?
Zinc modulates GABA-A receptors and can alter inhibitory neurotransmission.
Can CRISPR be used to study IPSPs?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of IPSP-related genes.
What are miniature IPSCs?
Miniature IPSCs are small, spontaneous inhibitory currents that reflect quantal release of neurotransmitter.
Conclusion
Inhibitory postsynaptic potentials (GO:0060080) are fundamental to neural circuit function, providing the brake that balances excitation and enables complex information processing [1, 4]. Dysregulation of IPSPs contributes to autism, epilepsy, and other neurological disorders. Advances in CRISPR gene editing now allow researchers to precisely manipulate the genes underlying IPSP generation and regulation, opening new avenues for therapeutic development. EDITGENE's comprehensive services support every step of this research, from model generation to high-throughput screening.
References
- 1. Atif M et al.. 2019. GluClR-mediated inhibitory postsynaptic currents reveal targets for ivermectin and potential mechanisms of ivermectin resistance.. PLoS Pathog 15(1):e1007570 PMID: 30695069
- 2. Buss EW et al.. 2024. HCN1 hyperpolarization-activated cyclic nucleotide-gated channels enhance evoked GABA release from parvalbumin-positive interneurons.. Proc Natl Acad Sci U S A 121(42):e2319246121 PMID: 39378096
- 3. Meunier JM et al.. 1973. [Electrical nature of the biphasic (excitatory-inhibitory) postsynaptic potential transmitted between 2 giant neurons from Aplysia].. Arch Ital Biol 111(3-4):305-22 PMID: 18847033
- 4. Leung LS et al.. 2025. Inhibitory Postsynaptic Potentials Participate in Intracellular and Extracellular Theta Rhythms in the Hippocampus: A Personal Narrative.. Hippocampus 35(1):e23660 PMID: 39670347
- 5. Lin CH et al.. 2025. Synaptic Deficits in Adnp-Mutant Mice Are Ameliorated by Histone Demethylase LSD1 Inhibition.. Autism Res 18(7):1342-1355 PMID: 40536108
- 6. Tóth K. 2011. Zinc in neurotransmission.. Annu Rev Nutr 31:139-53 PMID: 21548772
- 7. Popescu IR et al.. 2010. Synchronized bursts of miniature inhibitory postsynaptic currents.. J Physiol 588(Pt 6):939-51 PMID: 20123785
- 8. Takahashi N et al.. 2016. Subcellular Imbalances in Synaptic Activity.. Cell Rep 14(6):1348-1354 PMID: 26854220
